SAREPTA THERAPEUTICS INC SAREPT - stock earnings
0L35.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -40.9 million USD | 331.8 million USD |
| 2023Q2 | -23.9 million USD | 261.2 million USD |
| 2023Q1 | -516.8 million USD | 253.5 million USD |
| 2022Q4 | -109.2 million USD | 258.4 million USD |
| 2021Q3 | -48.1 million USD | 189.4 million USD |
| 2021Q2 | -81.4 million USD | 164.1 million USD |
| 2021Q1 | -167.3 million USD | 146.9 million USD |
| 2020Q4 | -189.3 million USD | 145.1 million USD |
| 2020Q3 | -196.5 million USD | 143.9 million USD |
0L35.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -703.5 million USD | 933.0 million USD |
| 2021 | -418.8 million USD | 701.9 million USD |
| 2020 | -554.1 million USD | 540.1 million USD |
| 2019 | -715.1 million USD | 380.8 million USD |
| 2018 | -361.9 million USD | 301.0 million USD |
| 2017 | -50.7 million USD | 154.6 million USD |
| 2016 | -267.3 million USD | 5.4 million USD |
0L35.L
Price: $129.94
52 week price:
Earnings Per Share: -4.29 USD
P/E Ratio: -29.89
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 105.9 million